34
Participants
Start Date
May 2, 2019
Primary Completion Date
September 3, 2024
Study Completion Date
September 3, 2024
Onapristone ER
50 mg PO BID (with dosage adjustments) until POD, unacceptable toxicity or withdrawal of consent.
Onapristone ER + Anastrozole
Onapristone ER Patients will take 50 PO BID in the form of two 20 mg tablets and one 10 mg tablet taken with food and water twice daily. Patients will be prescribed anastrozole 1mg PO QD. Anastrozole will be taken once daily in the AM with patients morning dose of onapristone ER.
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Rockville Centre, Rockville Centre
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Collaborators (1)
Context Therapeutics Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER